Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam R Glassman

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
JAMA Ophthalmology|November 11, 2021
Managing Center-Involved Diabetic Macular Edema With Good Visual AcuityJennifer K Sun, Adam R Glassman, Lee M Jampol
JAMA Ophthalmology|June 19, 2015
Comparative Effectiveness Trial for Diabetic Macular Edema: Three Comparisons for the Price of 1 Study From the Diabetic Retinopathy Clinical Research NetworkLee M Jampol, Adam R Glassman, Neil M Bressler
JAMA|June 11, 2014
Revolution to a new standard treatment of diabetic macular edemaLee M Jampol, Neil M Bressler, Adam R Glassman
Ophthalmology|October 16, 2018
ReplyAdam R Glassman, Elia J Duh, Danni Liu, et al.
JAMA Ophthalmology|February 2, 2023
Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular EdemaDavid W Hutton, Adam R Glassman, Danni Liu, et al.
Investigative Ophthalmology & Visual Science|April 7, 2018
Changes in Blood Pressure and Urine Albumin-Creatinine Ratio in a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular EdemaAdam R Glassman, Danni Liu, Lee M Jampol, et al.
Ophthalmology|April 6, 2010
A proposed method of logarithmic transformation of optical coherence tomography data for use in clinical researchFrederick L Ferris, Kellee M Miller, Adam R Glassman, et al.
JAMA Ophthalmology|August 18, 2016
Elimination of Topical Antibiotics for Intravitreous Injections and the Importance of Using Povidone-Iodine: Update From the Diabetic Retinopathy Clinical Research NetworkAbdhish R Bhavsar, Adam R Glassman, Cynthia R Stockdale, et al.
Ophthalmology|December 21, 2016
ReplyJohn A Wells, Adam R Glassman, Allison R Ayala, et al.
JAMA Ophthalmology|July 11, 2014
Evaluation of results 1 year following short-term use of ranibizumab for vitreous hemorrhage due to proliferative diabetic retinopathyAbdhish R Bhavsar, Karisse Torres, Adam R Glassman, et al.
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
JAMA Ophthalmology|November 11, 2021
Managing Center-Involved Diabetic Macular Edema With Good Visual AcuityJennifer K Sun, Adam R Glassman, Lee M Jampol
JAMA Ophthalmology|June 19, 2015
Comparative Effectiveness Trial for Diabetic Macular Edema: Three Comparisons for the Price of 1 Study From the Diabetic Retinopathy Clinical Research NetworkLee M Jampol, Adam R Glassman, Neil M Bressler
JAMA|June 11, 2014
Revolution to a new standard treatment of diabetic macular edemaLee M Jampol, Neil M Bressler, Adam R Glassman
Ophthalmology|October 16, 2018
ReplyAdam R Glassman, Elia J Duh, Danni Liu, et al.
JAMA Ophthalmology|February 2, 2023
Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular EdemaDavid W Hutton, Adam R Glassman, Danni Liu, et al.
Investigative Ophthalmology & Visual Science|April 7, 2018
Changes in Blood Pressure and Urine Albumin-Creatinine Ratio in a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular EdemaAdam R Glassman, Danni Liu, Lee M Jampol, et al.
Ophthalmology|April 6, 2010
A proposed method of logarithmic transformation of optical coherence tomography data for use in clinical researchFrederick L Ferris, Kellee M Miller, Adam R Glassman, et al.
JAMA Ophthalmology|August 18, 2016
Elimination of Topical Antibiotics for Intravitreous Injections and the Importance of Using Povidone-Iodine: Update From the Diabetic Retinopathy Clinical Research NetworkAbdhish R Bhavsar, Adam R Glassman, Cynthia R Stockdale, et al.
Ophthalmology|December 21, 2016
ReplyJohn A Wells, Adam R Glassman, Allison R Ayala, et al.
JAMA Ophthalmology|July 11, 2014
Evaluation of results 1 year following short-term use of ranibizumab for vitreous hemorrhage due to proliferative diabetic retinopathyAbdhish R Bhavsar, Karisse Torres, Adam R Glassman, et al.
Pageof 13